2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells
Chimeric antigen receptors are engineered receptors that combine a new specificity with an immune cell to target cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. CAR-T cells are a new type of treatment that uses living cells that have been transformed.
2018 (3rd) International Innovative Forum on Biomedical Materials and Tissue Repair & ReGeneration
In response to China's 13th five-year plan for new medical materials, this forum on tissue repair & reGeneration focuses on key technologies like 3D bioprinting, surface biofunctionalization and modification of materials, aiming to achieve innovation, cooperation and win-win across the borders of all countries.
2018 Symposium on Cancer Evolution and HeteroGeneity
HeteroGeneity is a major challenge in cancer treatment, which has a profound impact on cancer evolution & metastasis and drug resistance. With the developments of new technologies, there emerge successive achievements with great significance on clinical therapeutics. This symposium will focus on cancer heteroGeneity, promoting the clinical translation of research.
2018 Forum on Next Generation High Sensitivity Testing Technology and Application
Including topics like liquid biopsy, microfluidics and exosomes, this forum will focus on basic research, clinical application, technology R&D as well as industrialization. Bioon's missions are to pave the way for discovery of new biomarkers and to facilitate developments of in vitro diagnostics ( IVD ) & early cancer detection!
2018 International Conference on Gene Editing and Gene Therapy
Promoting the reasonable application and clinical translation of Gene editing technology iss of great importance. In addition, there are many researchers and clinicians caring about progress of Gene therapy. Therefore, Bioon is going to hold the 2018 International Conference on Gene Editing and Gene Therapy, so as to improve exchange and cooperation among all sides.